Your session is about to expire
← Back to Search
Online vs In-Person Fitness Programs for Arthritis (DEFT Trial)
N/A
Waitlist Available
Led By Kushang V Patel, PhD, MPH
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study months: 0, 4, 10, 16
Awards & highlights
DEFT Trial Summary
This trial will compare an online fitness program to an in-person program to see if the online program is just as effective.
Who is the study for?
This trial is for English-speaking adults with arthritis, including rheumatoid arthritis, gout, lupus, or fibromyalgia. Participants must be community-dwelling and either over 65 with moderate-to-severe functional limitations, low income, or living in rural areas; or aged 18-64 meeting the same conditions without age-related criteria.Check my eligibility
What is being tested?
The study compares two ways of delivering an exercise program called Enhance Fitness (EF) for managing arthritis: one group will do EF remotely while another will participate in-person. The goal is to see if remote EF is just as effective as the traditional in-person method.See study design
What are the potential side effects?
Since this trial involves physical exercise programs rather than medication, side effects may include typical exercise-related issues such as muscle soreness or strain. However, specific side effects are not detailed here.
DEFT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ study months: 0, 4, 10, 16
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study months: 0, 4, 10, 16
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
30-second Bicep Curl Test
30-second Sit-to-Stand Test
Depression
+5 moreOther outcome measures
Ability to Participate in Social Roles and Activities
Anxiety
Exercise Self-Efficacy Scale
+2 moreDEFT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Tele-EFExperimental Treatment1 Intervention
Remote delivery of Enhance Fitness.
Group II: In-person EFActive Control1 Intervention
In-person delivery of Enhance Fitness.
Find a Location
Who is running the clinical trial?
University of WashingtonLead Sponsor
1,749 Previous Clinical Trials
1,838,334 Total Patients Enrolled
7 Trials studying Arthritis
661 Patients Enrolled for Arthritis
Centers for Disease Control and PreventionFED
877 Previous Clinical Trials
22,477,894 Total Patients Enrolled
13 Trials studying Arthritis
5,451 Patients Enrolled for Arthritis
Kushang V Patel, PhD, MPHPrincipal InvestigatorUniversity of Washington
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a moderate-to-severe difficulty in moving or doing daily activities.You have a low household income.You live in a countryside or remote area.You have major vision or hearing problems that have not been fixed with treatment.This criterion refers to arthritis as defined by the Centers for Disease Control and Prevention (CDC).You live in a regular home, not in a hospital or nursing facility.For participants who are 65 years old or older:You have significant trouble with thinking and memory, as shown by a specific test score.Your doctor advises against exercising because of a health issue.People who are 65 years old or older.You have a hard time doing daily activities, have a low income, or live in a rural area.You have been diagnosed with arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia by a doctor or other health professional.
Research Study Groups:
This trial has the following groups:- Group 1: Tele-EF
- Group 2: In-person EF
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger